Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I can see them using a coating of this polymer in schools, items like chairs, countertops, cupboards, ect.
Hopefully government contractors will be in talks with SINT soon.
Glta!
Lpm
Good entry point here today.
0.0125 / 0.03 (1 x 1)
I quickly went over it.
I am by no means a genius on these investment instrument but the article seems to be talking about rights and not warrants.
I am old and I will review your posts again, though.
And I will research (best I can) what you wrote.
But as I understand it there are rights,warrants, and common shares involved.
I certainly don't mean to confuse you.
Rights can be bought just like warrants and stocks if they are or were made available.
Get back to you,but I don't know if I can answer your question.
Its probably better to call your broker and ask them.
I'm sorry ok.
Lpm
The part about $0.48 really needs to be corrected and is an error left in from a different conversion price before the reverse split.
This is repeating, but with more links, hopefully you can see?
Here is the recent Prospectus on iHub (from when they issued shares recently):
https://ih.advfn.com/stock-market/NASDAQ/sintx-technologies-SINT/stock-news/82723577/prospectus-filed-pursuant-to-rule-424b5-424b5
No. It does not.
Read some here at these links:
https://en.wikipedia.org/wiki/Warrant_(finance)
https://www.investopedia.com/ask/answers/how-to-exercise-stock-warrants/
You don't need people confusing you ok.
Let me know what you think, ok.
What are the details you have regarding these warrants?
Does it take 1 or 30 warrants for 1 share? What is the conversion price?
The issue is that even these base details are not clear to many - including me.
I have never converted my warrants.
I invest in warrants and buy and sell them just like stocks.
A warrant gives the investor the right to buy and not the obligation to buy a share at a prorated converted price if he so chooses too.
Good one.
On stocktwits, someone says that you need 30 warrants to get 1 share, I guess that is more in line if the stock did a reverse split, but the warrants did not.
Still see the $0.48 price though in the recent prospectus.
If the $0.48 is true and you need 30 shares ....
If the stock price is $2.00, than the warrants should be valued at $0.05 each
If the stock is $3.00, than the warrants should be valued at $0.084
Not sure on why the warrants wouldn't have been consolidated as well - that's what happens with options ....
Because what's the point of the warrants being repriced to lower if you need even more of them in order to exercise?
You get one benefit on one side, but on the other hand, you lose out.
This powder/ chemistry may be incorporated into all types of protective equipment, that in itself is probably going to do a lot to help fight the Coronavirus.
I don't know if they have intellectual patent rights yet (or if they can)but when this news gets around to people that manufacture things
..well am I safe to say that it may rocket this stock?
GLTA
$ $SINT $$$
https://www.biorxiv.org/content/10.1101/2020.06.19.159970v1.full.pdf
https://www.otcmarkets.com/filing/conv_pdf?id=14236955&guid=KdTFUeTzDw1Kk3h
From FORM 424B5
(Prospectus filed pursuant to Rule 424(b)(5))
Filed 06/24/20:
The Company has received positive testing results from an independent study that demonstrate the potential anti-viral properties of our silicon nitride. The
results suggest that silicon nitride may be useful in the reduction of the spread of COVID-19. The study results demonstrated that our unique grade of silicon
nitride inactivates the SARS-CoV-2 virus within a minute after exposure and has the potential to decrease the risk of viral disease spread on surfaces.
Studies have shown that coronavirus spreads between humans when an infected person coughs or sneezes. Also, the virus can remain active on a variety of
commonly touched surfaces for hours to days. We believe that by incorporating our unique composition of silicon nitride into products such as face masks,
and personal protective equipment, it is possible to manufacture surfaces that inactivate viral particles, thereby limiting the spread of the disease. [color=red] We
envision incorporating our silicon nitride into high-contact surfaces such as medical equipment, screens, countertops, and doorknobs in locations where viral[/color]
persistence is a concern, such as homes, casinos, and cruise ships. This believe this anti-viral discovery will open many new opportunities for us. In
composites, coatings, and mixtures, silicon nitride has maintained its antibacterial and osteogenic properties, even at small fractions. We believe that
incorporating our material into a variety of commonly-touched surfaces may discourage viral spread, and contribute to global health by reducing the risk of
disease
Typically warrants are exercisable at a fixed price.
But according to the updated prospectus, the public May 2018 warrants have the exercise price changed whenever the company offers shares at a lower price.
I am just saying what the prospectus says.
Of course, it seems too good to be true at this time.
Because current price of $2 less the exercise price of $0.48 is far higher than the $0.02 Friday closing price.
The original exercise price was $1.60
See here:
https://www.globenewswire.com/news-release/2018/05/14/1502087/0/en/Amedica-Corporation-Announces-Closing-of-15-000-000-Public-Offering-of-Units-Consisting-of-Convertible-Preferred-Stock-and-Warrants.html
The price has come down to $0.48 because of the company selling more share at lower prices.
At the time of issuance(2008) the common stock was valued much higher.
The warrant was valued at .48 and is a reflected value of the strike price. ( a set price)
Right now the stock is valued very low and also the warrants are too.
In warrant trading, when the common stock goes up the warrant value increases too.
If the common stock reaches the same price as when it was originally issued then it would also be that the warrant price would be back at .48 cents again.
But would scream much higher if the common went up past it's original strike price.
Warrants have a greater return on your buck. Ok.
Warrants are traded just like stocks. They can be bought or sold just like stocks.
The advantage of a warrant is that you can buy them at a price that is much less than the common stock price and when the common goes up the warrant goes up as well but at a greater percentage rate.
Investopedia has an easy read on warrants, check them out.
Its something that once read an understood then it becomes clear of how they work.
In my opinion warrants are super!
Maybe as an example you could examine Ship and shipw
They might show how the common and the warrant reflect each other.
Best to read about warrants and to know how they work though ok.
Good luck.
Simplified:
The warrants are exercisable at $0.48 which is the lowest price that the company has issued shares.
Whenever the company issues shares the exercise price decreases the lowest offered price.
The issue is if this is true why are these trading this low?
It clearly says public offering of warrants .... which is what AMDDW is?
This is from the recent Prospectus, I have copied quite a bit because the bottom paragraph covers the repricing.
The issue at this point is why are the warrants trading this low?
May 2018 Public Offering Warrants
On May 14, 2018, we issued 11,370,000 common stock warrants (the “May 2018 Warrants”) in a public offering. The material terms and provisions of the May 2018 Warrants are summarized below. This summary of the May 2018 Warrants is not complete. For the complete terms of the May 2018 Warrants, you should refer to the form of May 2018 Warrant filed as an exhibit to the registration statement of which this prospectus forms a part.
Pursuant to a warrant agency agreement between us and American Stock Transfer & Trust Company, LLC, as warrant agent, the May 2018 Warrants were issued in book-entry form and are represented only by one or more global warrants deposited with the warrant agent, as custodian on behalf of The Depository Trust Company, or DTC, and registered in the name of Cede & Co., a nominee of DTC, or as otherwise directed by DTC.
Exercisability, Exercise Price and Term. The May 2018 Warrants entitle the holder to purchase shares of our common stock at an exercise price equal to $0.48 per share. The May 2018 Warrants were exercisable immediately and expire on the five-year anniversary of the issuance date. The holder of a May 2018 Warrant will not be deemed a holder of our underlying common stock until the May 2018 Warrant is exercised, except as set forth in the May 2018 Warrants.
The exercise price and the number of shares issuable upon exercise of the May 2018 Warrants is subject to appropriate adjustment, similar to that described with respect to the Series B Preferred Stock above, in the event of recapitalization events, stock dividends, stock splits, stock combinations, reclassifications, reorganizations or similar events affecting our common stock. Subject to certain exclusions contained in the May 2018 Warrant, the exercise price is also subject to adjustment in the event that we sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any common stock or common stock equivalents (as defined in the May 2018 Warrants), at an effective price per share less than the exercise price then in effect (including in the event we issued Series B Preferred Stock at a conversion price lower than the initial conversion price of the Series B Preferred Stock).
News probably after hours of completion of share purchases.
GLTA
The company's silicon nitride powder shows promise as a coronavirus treatment
https://www.benzinga.com/news/20/06/16332342/why-sintx-technologies-stock-is-trading-higher-today
Sintx Tech under pressure on equity offering 06/23/20
https://seekingalpha.com/news/3585363-sintx-tech-under-pressure-on-equity-offering?utm_source=otcmarkets&utm_medium=referral
SINTX Technologies Announces Publication of Study to Reduce the Spread and Transfer of Coronavirus
https://www.otcmarkets.com/stock/AMDDW/news/story?e&id=1631463
Followers
|
1
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
21
|
Created
|
06/24/20
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |